FL
Frazier LifeSciences Acquisition Corporation
Venture Capital
Blank-check company (SPAC) sponsored by Frazier Life Sciences that raised capital to merge with a biopharmaceutical company; combined with NewAmsterdam Pharma in 2022.
Seattle · 1+ investments · 1 portfolio companies
Public
Biotech
- Headquarters
- Seattle
- Founded
- 2020
- AUM
- $100.0M
- Portfolio Company
- 1
- Total Investment
- 1
- Last Investment
- Feb 2024
- Geographic Focus
- United States
Investment Thesis
Formed to leverage Frazier Life Sciences' healthcare investing track record to identify and merge with a promising private biopharma company.
Frazier LifeSciences Acquisition Corporation is a Venture Capital firm based in Seattle. It has made 1 investment in Biotech, including NewAmsterdam Pharma.
Portfolio1
Co-investors3
Sign up to view co-investors
3 co-investors across 3 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×2 · Private Equity ×1
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/frazier-lifesciences-acquisition-corporation"><img src="https://indexed.vc/api/badge/investor/frazier-lifesciences-acquisition-corporation" alt="Frazier LifeSciences Acquisition Corporation on Indexed.vc" width="260" height="76" /></a>